Cutting-edge New Zealand research into a new cancer treatment using a patient's own immune cells suggests it could be safer and more effective than existing treatments.
Twenty-one patients with blood cancer (B-cell non-Hodgkin lymphoma) - who had already exhausted conventional treatments - took part in the trial, in which their own immune cells were modified genetically to make CAR T-cells.